Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hübschmann

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Nature Communications|January 12, 2018
Integrative genomic and transcriptomic analysis of leiomyosarcomaPriya Chudasama, Sadaf S Mughal, Mathijs A Sanders, et al.
Cancer Cell|March 4, 2022
The proteogenomic subtypes of acute myeloid leukemiaAshok Kumar Jayavelu, Sebastian Wolf, Florian Buettner, et al.
The New England Journal of Medicine|November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell TherapyGuido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Nature Communications|April 9, 2026
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorMarcus Renner, Małgorzata Oleś, Nagarajan Paramasivam, et al.
Cell Stem Cell|May 6, 2022
Antigen presentation safeguards the integrity of the hematopoietic stem cell poolPablo Hernández-Malmierca, Dominik Vonficht, Alexandra Schnell, et al.
Nature Communications|May 10, 2022
The genomic and transcriptional landscape of primary central nervous system lymphomaJosefine Radke, Naveed Ishaque, Randi Koll, et al.
Nature Medicine|October 15, 2025
Germany's national genomDE strategyAndreas Till, Roman A Siddiqui, Christian Altbürger, et al.
Med (New York, N.Y.)|March 19, 2025
Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumorsLino Möhrmann, Lysann Rostock, Maximilian Werner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2022
Gene expression-based prediction of pazopanib efficacy in sarcomaChristoph E Heilig, Andreas Laßmann, Sadaf S Mughal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2022
Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinomaPaula Hoffmeister-Wittmann, Andreas Mock, Federico Nichetti, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Nature Communications|January 12, 2018
Integrative genomic and transcriptomic analysis of leiomyosarcomaPriya Chudasama, Sadaf S Mughal, Mathijs A Sanders, et al.
Cancer Cell|March 4, 2022
The proteogenomic subtypes of acute myeloid leukemiaAshok Kumar Jayavelu, Sebastian Wolf, Florian Buettner, et al.
The New England Journal of Medicine|November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell TherapyGuido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Nature Communications|April 9, 2026
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorMarcus Renner, Małgorzata Oleś, Nagarajan Paramasivam, et al.
Cell Stem Cell|May 6, 2022
Antigen presentation safeguards the integrity of the hematopoietic stem cell poolPablo Hernández-Malmierca, Dominik Vonficht, Alexandra Schnell, et al.
Nature Communications|May 10, 2022
The genomic and transcriptional landscape of primary central nervous system lymphomaJosefine Radke, Naveed Ishaque, Randi Koll, et al.
Nature Medicine|October 15, 2025
Germany's national genomDE strategyAndreas Till, Roman A Siddiqui, Christian Altbürger, et al.
Med (New York, N.Y.)|March 19, 2025
Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumorsLino Möhrmann, Lysann Rostock, Maximilian Werner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2022
Gene expression-based prediction of pazopanib efficacy in sarcomaChristoph E Heilig, Andreas Laßmann, Sadaf S Mughal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2022
Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinomaPaula Hoffmeister-Wittmann, Andreas Mock, Federico Nichetti, et al.
Pageof 10